Ondansetron Injection BP 4mg/2ml

Antiemetic – Selective 5-HT3 Receptor Antagonist

Ondansetron Injection BP 4 mg/2 ml is a selective 5-HT3 receptor antagonist formulated for parenteral administration. It is widely used in hospitals and oncology settings to control acute and delayed nausea and vomiting. Manufactured in accordance with British Pharmacopoeia (BP) standards, this antiemetic injection ensures high quality, safety, and therapeutic reliability. The formulation supports effective symptom control in chemotherapy, radiotherapy, and postoperative care, contributing to improved patient comfort and recovery outcomes. Produced under stringent quality systems, the product aligns with responsible and sustainable pharmaceutical manufacturing practices.

Key Information

Active Ingredient Ondansetron (4 mg/2 mL)

Dosage Form Tablet

Pack Size 5 x 2 mL Ampoules

Storage Controlled room temperature. Protect from light.

Benefits

Rapid and effective control of nausea and vomiting

Highly effective in chemotherapy and postoperative settings

Well-tolerated antiemetic therapy

BP-compliant quality assurance

Suitable for hospital and clinical use

Usage Instructions

Administered intravenously or intramuscularly by a qualified healthcare professional

Dosage depends on indication, patient condition, and clinical protocol

IV administration should be given slowly as recommended

For professional medical use only

Mechanism of Action

Ondansetron works by selectively blocking serotonin (5-HT3) receptors located in the central nervous system and gastrointestinal tract. By inhibiting serotonin-mediated signaling in the chemoreceptor trigger zone and vagal nerve terminals, it effectively prevents nausea and vomiting.

Indications

Ondansetron Injection BP 4 mg/2 ml is indicated for the prevention and treatment of nausea and vomiting associated with:

Chemotherapy-induced nausea and vomiting (CINV)

Radiotherapy-induced nausea and vomiting

Postoperative nausea and vomiting (PONV)

Acute gastroenteritis–related severe vomiting (under medical supervision)

Side Effects

Common or possible side effects include:

Headache

Constipation

Dizziness

Fatigue

Transient changes in liver enzymes

Rare: QT interval prolongation

Precautions

Use cautiously in patients with cardiac rhythm disorders

Monitor patients with electrolyte imbalance

Caution in hepatic impairment

Avoid combining with other QT-prolonging medications unless supervised

Use during pregnancy only if clearly necessary

Contraindications

Known hypersensitivity to ondansetron or other 5-HT3 receptor antagonists

Concomitant use with apomorphine

Patients with congenital long QT syndrome

Severe hypersensitivity reactions to similar antiemetic agents

Frequently Asked Questions

Find answers to common questions about Ondansetron Injection BP 4mg/2ml

1 What is Ondansetron Injection BP used for?

It is used to prevent and treat nausea and vomiting caused by chemotherapy, radiotherapy, and surgery.

2 How quickly does Ondansetron Injection work?

It typically provides rapid relief when administered intravenously.

3 Can it be used in children?

It may be used under strict medical supervision with appropriate dosing.

4 Does this product comply with BP standards?

Yes, it is manufactured according to British Pharmacopoeia specifications.